Patient Perspectives and Preferences Regarding Gout and Gout Management Impact on Adherence
- 주제(키워드) Gout , Disease Management , Perspective , Patient Preference
- 주제(기타) Medicine, General & Internal
- 설명문(일반) [Chung, Min Kyung; Lee, Jisoo] Ewha Womans Univ, Coll Med, Dept Internal Med, Div Rheumatol, 1071 Anyangchoen Ro, Seoul 07985, South Korea; [Kim, Sung Soo] Univ Ulsan, Coll Med, Gangneung Asan Hosp, Div Rheumatol,Dept Internal Med, Kangnung, South Korea; [Cheon, Yun Hong] Gyeongsang Natl Univ Hosp, Dept Internal Med, Div Rheumatol, Jinju, South Korea; [Hong, Seung Jae] Kyung Hee Univ, Kyung Hee Univ Hosp, Sch Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Choi, Hyo Jin; Seo, Mi Ryoung] Gachon Univ, Coll Med, Gil Med Ctr, Dept Internal Med,Div Rheumatol, Incheon, South Korea; [Hwang, Jiwon] Sungkyunkwan Univ, Sch Med, Samsung Changwon Hosp, Div Rheumatol,Dept Internal Med, Chang Won, South Korea; [Ahn, Joong Kyong] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Lee, Sang Heon; Min, Hong Ki] Konkuk Univ, Med Ctr, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Cha, Hoon Suk] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Lee, Shin Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea; [Lee, Jennifer] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Moon, Ki Won] Kangwon Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Chunchon, South Korea; [Lee, Chang Keun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Kim, Hyun Ok; Suh, Young Sun] Gyeongsang Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Jinju, South Korea; [Shim, Seung Cheol; Kang, Seong Wook; Kim, Jinhyun] Chungnam Natl Univ, Chungnam Natl Univ Hosp, Sch Med, Div Rheumatol,Dept Internal Med, Daejeon, South Korea; [Choi, Sang Tae; Song, Jung Soo] Chung Ang Univ, Sch Med, Dept Internal Med, Div Rheumatol, 102 Heukseok Ro, Seoul 06973, South Korea
- 등재 SCIE, SCOPUS, KCI등재
- 발행기관 KOREAN ACAD MEDICAL SCIENCES
- 발행년도 2021
- 총서유형 Journal
- URI http://www.dcollection.net/handler/ewha/000000183446
- 본문언어 영어
- Published As http://dx.doi.org/10.3346/jkms.2021.36.e208
초록/요약
Background: Patient-centered management is becoming increasingly important in gout, but there are limited studies exploring patients' perspectives and preferences. We aimed to investigate patients' perspectives and preferences regarding gout and gout management, and their impacts on adherence to urate lowering therapy (ULT). Methods: A paper-based survey was performed in patients with gout seen at the rheumatology outpatient clinics of 16 tertiary hospitals. The survey included questions regarding demographics, comorbidities, gout attacks, current treatment and adherence, and patients' perspectives and preferences regarding gout and gout management. Multivariate regression analysis was performed to determine the factors associated with ULT adherence. Results: Of 809 surveyed patients with gout, 755 (94.5%) were using ULT. Among those using ULT, 89.1% had >= 80% adherence to ULT. Majority of the patients knew management strategies to some extent (94.8%), perceived gout as a life-long disease (91.2%), and were making efforts toward practicing at least one lifestyle modification (89.2%). Most patients (71.9%) obtained information about gout management during their clinic visits. Approximately half of the patients (53.6%) preferred managing their disease with both ULT and lifestyle modification, 28.4% preferred ULT only, and 17.4% preferred lifestyle modification only. Adherence was better in patients with older age (odds ratio [OR], 1.03), those with better knowledge of gout management strategies (OR, 3.56), and those who had preference for ULT (OR, 2.07). Conclusion: Patients' perspectives and management preferences had high impacts on adherence to ULT in gout. Consideration of patients' perspectives and preferences is important for achieving the desired clinical outcome in gout.
more